| INMED PHARMACEUTICALS |
| Kanada |
| Gesundheit |
| CA4576377002 / A40UCN |
| MWG (Frankfurt) / INM (NASDAQ) |
| FRA:MWG, ETR:MWG, MWG:GR, NASDAQ:INM |
| - |
| https://www.inmedpharma.c.. |
|
InMed Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in Vancouver, Canada. The company focuses on researching and developing cannabinoid-based pharmaceutical products targeting diseases with high unmet medical needs, particu..
>Volltext.. |
| 1.82 Mio. EUR |
| -2.33 Mio. EUR |
| 2.79 Mio. EUR |
| -6.85 Mio. EUR |
| -7.32 Mio. EUR |
| -2.22 EUR |
| 0.36 Mio. EUR |
| 4.44 Mio. EUR |
| - |
| 2.35 |
| -38.25% |
| 4.13% |
| - |
| - |
| - |
| - |
| INMED |
| 19.05.26 |
|
||||
|
||||
|
||||
|
||||
|